viernes, 24 de mayo de 2019

Dana-Farber prevails in immunotherapy dispute over patents

Dana-Farber prevails in immunotherapy dispute over patents

Cancer Briefing

STAT Plus: Dana-Farber prevails in immunotherapy dispute over patents behind blockbuster drug

By ELIZABETH COONEY


SUZANNE KREITER/THE BOSTON GLOBE
A court ruling will allow Dana-Farber to license the intellectual property behind the patents to companies developing new therapies.

No hay comentarios: